Cargando…

The Effect of Alzheimer’s Disease-Associated Genetic Variants on Longevity

Human longevity is influenced by the genetic risk of age-related diseases. As Alzheimer’s disease (AD) represents a common condition at old age, an interplay between genetic factors affecting AD and longevity is expected. We explored this interplay by studying the prevalence of AD-associated single-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tesi, Niccolò, Hulsman, Marc, van der Lee, Sven J., Jansen, Iris E., Stringa, Najada, van Schoor, Natasja M., Scheltens, Philip, van der Flier, Wiesje M., Huisman, Martijn, Reinders, Marcel J. T., Holstege, Henne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724252/ https://www.ncbi.nlm.nih.gov/pubmed/34992629 http://dx.doi.org/10.3389/fgene.2021.748781

Ejemplares similares

Polygenic Risk Score of Longevity Predicts Longer Survival Across an Age Continuum
por: Tesi, Niccolo’, et al.
Publicado: (2020)

Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease
por: Tesi, Niccolò, et al.
Publicado: (2020)

Centenarian controls increase variant effect sizes by an average twofold in an extreme case–extreme control analysis of Alzheimer’s disease
por: Tesi, Niccolò, et al.
Publicado: (2018)

Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies
por: van der Lee, Sven J., et al.
Publicado: (2021)

snpXplorer: a web application to explore human SNP-associations and annotate SNP-sets
por: Tesi, Niccolo, et al.
Publicado: (2021)

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score
por: Ebenau, Jarith L., et al.
Publicado: (2021)

The phenotypic and genotypic association of grip strength with frailty, physical performance and functional limitations over time in older adults
por: Stringa, Najada, et al.
Publicado: (2023)

Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study
por: Beker, Nina, et al.
Publicado: (2020)

Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions
por: Reus, Lianne M., et al.
Publicado: (2021)

Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy
por: Holstege, Henne, et al.
Publicado: (2017)

What does heritability of Alzheimer’s disease represent?
por: Baker, Emily, et al.
Publicado: (2023)

Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results from Three Longitudinal Cohort Studies
por: Stringa, Najada, et al.
Publicado: (2020)

Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer’s Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity
por: Louwersheimer, Eva, et al.
Publicado: (2017)

Amsterdam Dementia Cohort: Performing Research to Optimize Care
por: van der Flier, Wiesje M., et al.
Publicado: (2018)

The Longitudinal Aging Study Amsterdam: cohort update 2019 and additional data collections
por: Hoogendijk, Emiel O., et al.
Publicado: (2019)

Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families
por: Mol, Merel O., et al.
Publicado: (2022)

Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
por: Pelkmans, Wiesje, et al.
Publicado: (2021)

Neuropsychological Test Performance of Cognitively Healthy Centenarians: Normative Data From the Dutch 100‐Plus Study
por: Beker, Nina, et al.
Publicado: (2018)

Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
por: Pelkmans, Wiesje, et al.
Publicado: (2019)

A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds
por: Cohn‐Hokke, Petra E., et al.
Publicado: (2016)

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
por: van der Lee, Sven J., et al.
Publicado: (2019)

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
por: van der Lee, Sven J., et al.
Publicado: (2020)

Identifying Aging and Alzheimer Disease–Associated Somatic Variations in Excitatory Neurons From the Human Frontal Cortex
por: Zhang, Meng, et al.
Publicado: (2023)

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition
por: Dicks, Ellen, et al.
Publicado: (2020)

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
por: Kleineidam, Luca, et al.
Publicado: (2020)

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology
por: Rosenberger, Andrea FN, et al.
Publicado: (2014)

Exercise and Early-Onset Alzheimer's Disease: Theoretical Considerations
por: Hooghiemstra, Astrid M., et al.
Publicado: (2012)

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
por: Engels, Marjolein MA, et al.
Publicado: (2015)

Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline
por: Pelkmans, Wiesje, et al.
Publicado: (2022)

ABCA7 p.G215S as potential protective factor for Alzheimer's disease
por: Sassi, Celeste, et al.
Publicado: (2016)

Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory
por: de Haan, Willem, et al.
Publicado: (2009)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Hypertensive Disorders of Pregnancy Appear Not to Be Associated with Alzheimer's Disease Later in Life
por: Abheiden, Carolien N.H., et al.
Publicado: (2015)

Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer’s Disease. An MEG Study with Virtual Electrodes
por: Engels, Marjolein M. A., et al.
Publicado: (2016)

Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline
por: Beker, Nina, et al.
Publicado: (2021)

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
por: van der Schaar, Jetske, et al.
Publicado: (2022)

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease
por: Dicks, Ellen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibrahrmulddabda0smkbkitrdk